Citations

Showing 10 of 108094 citations.

Does obesity affect the outcomes in takotsubo cardiomyopathy? Analysis of the Nationwide Inpatient Sample database, 2010‐2014
Desai, Rupak , Singh, Sandeep , Baikpour, Maryam, Goyal, Hemant , Dhoble, Abhijeet , Deshmukh, Abhishek , Kumar, Gautam , Sachdeva, Rajesh , Sachdeva, Rajesh , Desai, Rupak

Mayo Clinic

Clinical Cardiology | June 19, 2018 | Volume: 41 | Issue: 8 | Pages: 1028-1034

10.1002/clc.22999 | PMID 29917260 Get It

BackgroundObesity can lead to increased oxidative stress which is one of the proposed mechanisms in the etiopathogenesis of takotsubo cardiomyopathy (TCM).HypothesisThe presence of obesity adversely impacts clinical outcomes in TCM patients.MethodsWe queried the Nationwide Inpatient Sample database (2010‐2014) to identify adult patients admitted with a principal diagnosis of TCM with and without obesity. We compared the categorical and continuous variables by Pearson χ2 and Student t test, respectively, in propensity‐score matched cohorts.ResultsThe study cohort comprised 612 obese TCM (weighted n = 3034) and 5696 nonobese TCM (weighted n = 28 186) patients. Obese TCM patients were more often younger and private‐insurance enrollees. Cardiac complications including acute myocardial infarction (9.0% vs 7.4%; P = 0.04), cardiac arrest (2.3% vs. 0.4%; P < 0.001), cardiogenic shock (4.3% vs. 3.2%; P = 0.03), congestive heart failure (5.0% vs. 3.8%; P = 0.02), respiratory failure (12.9% vs. 11.0%; P = 0.021) and use of mechanical hemodynamic support (Impella; 0.2% vs. 0.0%, P = 0.02) were significantly higher among obese TCM patients. There were no significant differences between the 2 groups in all‐cause mortality (1.0% vs. 0.8%; P = 0.35), arrhythmia (24.5% vs. 22.7%, P = 0.123), length of stay (3.7 ±3.5 vs. 3.7 ±3.6 days; P = 0.68), and total hospital charges ($40 780.16 vs. $42 575.14; P = 0.08).ConclusionsObese TCM patients were more susceptible to developing TCM‐related cardiac complications than were nonobese TCM patients, without any impact on all‐cause in‐hospital mortality, LOS, and hospital charges.
Systematic review and network meta‐analysis: first‐ and second‐line biologic therapies for moderate‐severe Crohn's disease
Singh, Siddharth , Fumery, Mathurin, Sandborn, William J. , Murad, M. Hassan , Singh, S , Sandborn, W J , Murad, M Hassan

Mayo Clinic

Alimentary Pharmacology & Therapeutics | June 19, 2018 | Volume: 48 | Issue: 4 | Pages: 394-409

10.1111/apt.14852 | PMID 29920733 Get It

SummaryBackgroundThere are limited data to inform positioning of agents for treating moderate‐severe Crohn's disease (CD).AimWe assessed comparative efficacy and safety of first‐line (biologic‐naïve) and second‐line (prior exposure to anti‐tumour necrosis factor [TNF]‐α) agents) biologic therapy for moderate‐severe CD, through a systematic review and network meta‐analysis, and appraised quality of evidence (QoE) using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach.MethodsWe identified randomised controlled trials (RCTs) in adults with moderate‐severe CD treated with approved anti‐TNF agents, anti‐integrin agents and anti‐IL12/23 agents, first‐line or second‐line, and compared with placebo or another active agent. Efficacy outcomes were induction and maintenance of clinical remission; safety outcomes were serious adverse events and infections. Network meta‐analyses were performed, and ranking was assessed using surface under the cumulative ranking (SUCRA) probabilities.ResultsNo head‐to‐head trials were identified. In biologic‐naïve patients, infliximab (SUCRA,0.93) and adalimumab (SUCRA,0.75) were ranked highest for induction of clinical remission (moderate QoE). In patients with prior anti‐TNF exposure, adalimumab (SUCRA, 0.91; low QoE, in patients with prior response or intolerance to anti‐TNF agents) and ustekinumab (SUCRA, 0.71) were ranked highest for induction of clinical remission. In patients with response to induction therapy, adalimumab (SUCRA, 0.97) and infliximab (SUCRA, 0.68) were ranked highest for maintenance of remission. Ustekinumab had lowest risk of serious adverse events (SUCRA, 0.72) and infection (SUCRA, 0.71; along with infliximab, SUCRA, 0.83) in maintenance trials.ConclusionIndirect comparisons suggest that infliximab or adalimumab may be preferred first‐line agents, and ustekinumab a preferred second‐line agent, for induction of remission in patients with moderate‐severe CD. Head‐to‐head trials are warranted.
Evolution of Validated Biomarkers and Intraoperative Parameters in the Development of Postoperative ARDS
Yadav, Hemang , Bartley, Adam C. , Keating, Sheila M. , Meade, Laurie, Norris, Philip J. , Carter, Rickey E. , Kor, Daryl J. , Bartley, Adam, Meade, Laurie A., Carter, Rickey E , Gajic, Ognjen

Mayo Clinic

Respiratory Care | June 19, 2018 | Volume: 63 | Issue: 11 | Pages: 1331-1340

10.4187/respcare.06103 | PMID 29921605 Get It

BACKGROUND: Patients who develop ARDS from medical or traumatic causes typically present after the inciting event has already occurred. Postoperative ARDS is unique in that the inciting insult potentially responsible for ARDS is known ahead of time, which provides an opportunity to study the early pathophysiology of ARDS. The objective of this study was to better understand the early pathophysiology of postoperative ARDS through a temporal analysis of key biomarkers of interest. METHODS: We performed a case-control study of adults undergoing elective thoracic, aortic vascular, or cardiac surgery, which placed them at increased risk of developing postoperative ARDS. Biomarkers were measured at baseline, 2 h, and 6 h after the key intraoperative event believed to be responsible for ARDS. RESULTS: Of the 467 subjects enrolled, 26 developed ARDS and were matched to non-ARDS controls 1:2 based on age, sex, surgical procedure, and surgical lung injury prediction score. Patients with ARDS were more likely to have lower preoperative albumin ( P = .029), longer surgery ( P = .007), larger amounts of intraoperative fluid ( P = .036), and higher intraoperative peak inspiratory pressures ( P = .006). Baseline plasminogen activator inhibitor-1 levels were higher in the ARDS group ( P = .03). Changes in postoperative biomarker levels from baseline were greater in the ARDS group for interleukin-8 (baseline to 6 h, P = .02) and surfactant protein-D (baseline to 2 h, P = .009). CONCLUSIONS: Our study supported the hypothesis that dysregulated coagulation, inflammation, and epithelial injury are pathophysiologic features of early postoperative ARDS. Interleukin-8, plasminogen activator-1, and surfactant protein-D may help predict development of postoperative ARDS.
Shen-Shuai-Ning granule decreased serum concentrations of indoxyl sulphate in uremic patients undergoing peritoneal dialysis
Chen, Xujiao , Gao, Shouhong , Ruan, Mengna, Chen, Sixiu , Xu, Jing , Xing, Xiaohong , Pan, Xiaohong , Mei, Changlin , Mao, Zhiguo , Pan, Xiaohong

Mayo Clinic

Bioscience Reports | June 19, 2018 | Volume: 38 | Issue: 5 | Pages: No page available

10.1042/bsr20171694 | PMID 29921575 Get It

Clearance of protein-bound uremic toxins (PBUTs) by dialysis is a challenge in the treatment of uremic patients. Shen-Shuai-Ning (SSN), a traditional Chinese medicine formulation, has been used commonly in China to retard kidney disease progression and decrease uremic toxins in chronic kidney disease (CKD) patients, but the effects of SSN on serum PBUTs in dialysis patients were not investigated. We conducted a randomized controlled trial in patients on peritoneal dialysis (PD) at dialysis center of Changzheng Hospital to evaluate the effects of SSN on serum PBUTs. Participants with SSN intervention took 5 g SSN granule three times daily for 12 weeks, while the baseline medications and dialysis prescriptions remained during the study in all patients. The serum concentrations of indoxyl sulphate (IS) and p-cresol sulphate (PCS) were determined by HPLC/MS/MS and biochemical parameters were assessed during the study. Sixty PD patients were enrolled and randomly allocated into SSN group and control group. Total IS level was significantly lower in SSN group than in control group at week 4, 8, and 12 (27.28 ± 18.19, 29.73 ± 19.10, and 29.41 ± 17.61 mg/l compared with 39.25 ± 20.23, 44.86 ± 23.91, and 45.34 ± 33.52 mg/l, respectively). However, there were no statistical difference of total PCS, free forms of IS and PCS concentrations between SSN group and control group during 12 weeks follow-up. Administration of SSN granule orally decreased serum total IS level effectively in uremic patients on PD with good tolerance. Benefits of PD patients’ outcomes from IS reduction by SSN awaits further large size and long duration clinical trials to verify.
Wellness Opportunities: Sometimes It Is “Just Time Off”
Licatino, Lauren K. , Moeschler, Susan M. , Licatino, Lauren, Moeschler, Susan

Mayo Clinic

Journal of Graduate Medical Education | June 19, 2018 | Volume: 10 | Issue: 3 | Pages: 361-361

10.4300/jgme-d-18-00260.1 | PMID 29946409 Get It

Orthostatic Headache After Suboccipital Craniectomy Without CSF Leak: Two Case Reports
Montenegro, Monique M. , Cutsforth‐Gregory, Jeremy K.

Mayo Clinic

Headache: The Journal of Head and Face Pain | June 19, 2018 | Volume: 58 | Issue: 8 | Pages: 1238-1243

10.1111/head.13346 | PMID 29920678 Get It

Objective To review the clinical and radiographic characteristics of orthostatic headache following suboccipital craniectomy without CSF leak after encountering 2 such patients. Background Orthostatic headache may occur without CSF leak, suggesting alternative mechanisms for postural head pain in some patients. Methods Patients who were referred for orthostatic headache and suspected CSF leak within 1 year after suboccipital craniectomy but who had negative post‐operative head and spine MRI, normal radioisotope cisternography, and normal or elevated CSF opening pressure were identified and their medical records reviewed. Results Two patients satisfied all inclusion criteria. One underwent suboccipital craniectomy for treatment of Chiari malformation type I in adolescence; the same surgical approach was used to resect a posterior fossa meningioma in the second. Both patients had non‐orthostatic headache before surgery and newly developed orthostatic headache later. Delay from surgery to orthostatic headache onset was variable (2–9 months). Headaches were predominantly occipital and pressure‐like, worsened by upright posture, bending forward, and exertion. MRI consistently showed adequate decompression of the posterior fossa. Epidural blood patches were unhelpful in the one patient in whom they were performed. Conclusions Orthostatic headaches may develop after suboccipital craniectomy in the absence of CSF leak. Possible mechanisms include (1) scarring of the dura in the posterior fossa that leads to compensatory increased distensibility of lumbar dura and (2) sensitization of mechanosensitive dural nociceptors from altered skull‐dura apposition.
Volumetric laser endomicroscopy in the biliary and pancreatic ducts: a feasibility study with histological correlation
Mousa, Omar Y. , Krishna, Murli , Pursell, Khela R., Afsh, Mohammad, Harnois, Denise M. , Wolfsen, Herbert C. , Wallace, Michael B. , Lukens, Frank , Corral, Juan E. , Lukens, Frank J., Wallace, Michael B , Levink, Iris J. M. , Kröner, Paul T.

Mayo Clinic

Endoscopy | June 18, 2018 | Volume: 50 | Issue: 11 | Pages: 1089-1094

10.1055/a-0631-1634 | PMID 29913531 Get It

Abstract Background Volumetric laser endomicroscopy (VLE) provides circumferential images 3 mm into the biliary and pancreatic ducts. We aimed to correlate VLE images with the normal and abnormal microstructure of these ducts. Methods: Samples from patients undergoing hepatic or pancreatic resection were evaluated. VLE images were collected using a low-profile VLE catheter inserted manually into the biliary and pancreatic ducts ex vivo. Histological correlation was assessed by two unblinded investigators. Results 25 patients (20 liver and 5 pancreatic samples) and 111 images were analyzed. VLE revealed three histological layers: epithelium, connective tissue, and parenchyma. It identified distinctive patterns for primary sclerosing cholangitis (PSC), pancreatic cysts, neuroendocrine tumor, and adenocarcinoma adjacent to the pancreatic duct or ampulla. VLE failed to identify dysplasia in a dominant stricture and inflammatory infiltrates in PSC. Reflectivity measurements of the liver parenchyma diagnosed liver cirrhosis with high sensitivity. Conclusions VLE can identify histological changes in the biliary and pancreatic ducts allowing real-time diagnosis. Further studies are needed to measure the accuracy of VLE in a larger sample and to validate our findings in vivo.
Endoscopic Resection of Hemorrhaged Third Ventricle Cavernous Malformation: 2-Dimensional Operative Video
Palandri, Giorgio , Sorenson, Thomas J. , Zucchelli, Mino , Acciarri, Nicola, Mantovani, Paolo , Sturiale, Carmelo Lucio , Sorenson, Thomas, Palandri, Giorgio , Sturiale, Carmelo Lucio

Mayo Clinic

Operative Neurosurgery | June 18, 2018 | Volume: 16 | Issue: 2 | Pages: E51-E51

10.1093/ons/opy164 | PMID 29920585 Get It

Abstract Cavernous malformations of the third ventricle are uncommon vascular lesions. Evidence suggests that cavernous malformations in this location might have a more aggressive natural history due to their risk of intraventricular hemorrhage and hydrocephalus. 1 The gold standard of treatment is considered to be microsurgical gross total resection of the lesion. However, with progressive improvement in endoscopic capabilities, several authors have recently advocated for the role of minimally-invasive neuroendoscopy for resecting intraventricular cavernous malformations. 2-4 In this timely intraoperative video, we demonstrate the gross total resection of a third ventricle cavernous malformation that presented with hemorrhage via a right-sided trans-frontal neuroendoscopic approach.
Evaluation of the Impact of a senior mentor program on medical students’ geriatric knowledge and attitudes toward older adults
Garza, Maria Mendoza de la , Tieu, Christina, Schroeder, Darrell R. , Lowe, Kathleen, Tung, Ericka E. , Mendoza De La Garza, Maria, Schroeder, Darrell, Tung, Ericka, Schroeder, Darrell

Mayo Clinic

Gerontology & Geriatrics Education | June 18, 2018 | Volume: 39 | Issue: 3 | Pages: 316-325

10.1080/02701960.2018.1484736 | PMID 29912653 Get It

Importance of Variant Interpretation in Whole-Exome Molecular Autopsy
Shanks, Garrett W., Tester, David J. , Ackerman, Jaeger P., Simpson, Michael A. , Behr, Elijah R. , Ackerman, Michael J. , Behr, Elijah Raphael , White, Steven M.

Mayo Clinic

Circulation | June 18, 2018 | Volume: 137 | Issue: 25 | Pages: 2705-2715

10.1161/circulationaha.117.031053 | PMID 29915097 Get It

Background: Potentially lethal cardiac channelopathies/cardiomyopathies may underlie a substantial portion of sudden unexplained death in the young (SUDY). The whole-exome molecular autopsy represents the latest approach to postmortem genetic testing for SUDY. However, proper variant adjudication in the setting of SUDY can be challenging. Methods: From January 2012 through December 2013, 25 consecutive cases of SUDY from 1 to 40 years of age (average age at death 27±5.7 years; 13 white, 12 black) from Cook County, Illinois, were referred after a negative (n=16) or equivocal (n=9) conventional autopsy. A whole-exome molecular autopsy with analysis of 99 sudden death-susceptibility genes was performed. The predicted pathogenicity of ultrarare, nonsynonymous variants was determined using the American College of Medical Genetics guidelines. Results: Overall, 27 ultrarare nonsynonymous variants were seen in 16/25 (64%) victims of SUDY. Among black individuals, 9/12 (75%) had an ultrarare nonsynonymous variant compared with 7/13 (54%) white individuals. Of the 27 variants, 10 were considered pathogenic or likely pathogenic in 7/25 (28%) individuals in accordance with the American College of Medical Genetics guidelines. Pathogenic/likely pathogenic variants were identified in 5/16 (31%) of autopsy-negative cases and in 2/6 (33%) victims of SUDY with equivocal findings of cardiomyopathy. Overall, 6 pathogenic/likely pathogenic variants in 4/25 (16%) cases were congruent with the phenotypic findings at autopsy and therefore considered clinically actionable. Conclusions: Whole-exome molecular autopsy with gene-specific surveillance is an effective approach for the detection of potential pathogenic variants in SUDY cases. However, systematic variant adjudication is crucial to ensure accurate and proper care for surviving family members.